TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260508. A total of 19 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $653,000 | – | 296,727 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 296,727 | $653,000 | 0.14% |
| CVI Holdings, LLC | 16,288 | $36,000 | 0.08% |
| Anson Funds Management LP | 31,136 | $68,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,000 | $44,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 52,044 | $114,000 | 0.00% |
| UBS Group AG | 110 | $0 | 0.00% |
| NEXT Financial Group, Inc | 43 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 260 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 310 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |